About Us

Our Vision for the Future

To Save Lives with Early Detection of Lung Cancer

At VisionGate, our mission is to save lives through the early detection and prevention of cancer. Our cutting-edge technologies are designed to accurately and quickly detect early-stage lung cancer using a simple, non-intrusive test.

You’re in
Good Hands

We’re backed by a talented team of scientists, researchers, and doctors.

With over 150 years of combined experience, our team at VisionGate has considerable knowledge in the creation of cutting-edge technologies in fields including pharmaceuticals and diagnostics.

Consisting of scientists, researchers, and doctors with backgrounds in a broad range of fields, we’ve put our heads together to develop world class early stage lung cancer detection methods.

Meet Our Team
VisionGate has considerable knowledge in the creation of cutting-edge technologies in fields including pharmaceuticals and diagnostics
Pioneering Solutions because Living Cancer Free should be Easy

Pioneering Solutions

Because living your life well to a ripe age free of lung cancer should be an easy one.

Learn more about how many people are affected by lung cancer every year and how VisionGate is actively working towards saving lives with our early detection technology.

Our Partners

Like what you see? Join our team & help save lives.

Partnering with us for a greater purpose, VisionGate has strong clinical engagement with leading academic and healthcare institutions such as NYU Langone Cancer Center, The Swedish Cancer Institute, and Kaiser Permanente.

Our Technology

Our breakthrough technology helps detect early signs of lung cancer that otherwise may not be discovered. Through non-intrusive testing we’re able to detect the abnormal cells indicating lung cancer and lung dysplasia.

Non-Intrusive Testing

Sputum (phlegm) samples from a deep cough (LuCED° Lung Test) are collected over a three-day period using a take-home test kit.

AI-Powered Cancer Detection

Our AI-based classification of cells can identify 1,000 cell images per second and over 800 3D cell features at a 200 nanometer isotropic resolution.

Patented Cell-CT Imaging

High-resolution 3D images (Cell-CT™) of individual cells contained in the sputum measure hundreds of disease indicators and molecular markers in each cell.